Shugan Jieyu Capsules

DRUG2 trials

Sponsors

Sichuan Jishengtang Pharmaceutical Co., Ltd., Peking University

Conditions

Generalized Anxiety DisorderOutpatients or Inpatients With Depression

Phase 3

Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder

RecruitingNCT05772104

Sichuan Jishengtang Pharmaceutical Co., Ltd.Generalized Anxiety Disorder

Start: 2023-04-17End: 2025-06-01Target: 495Updated: 2024-12-18

Unknown Phase

A Multicenter Real-World Study Evaluating the Efficacy and Safety of Shugan Jieyu Capsules in the Treatment of Depression

Not yet recruitingNCT07785284

Peking UniversityOutpatients or Inpatients With Depression

Start: 2026-09-01End: 2028-06-01Target: 400Updated: 2026-09-08